Research Article

Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines

Figure 4

Effect of six tested compounds (3g, 3a, 3c, 3b, 3d, and 3e) on cell proliferation and cell cycle phases of HepG2. (a) Change in the cell cycle of untreated (cont.), 5-fluorouracil (5-FU), and treated HepG2 was analyzed using a flow cytometer. (b) The percentage of the cell population in the phases of the HepG2 cell cycle. Data were expressed for each bar as . from control, # from 5FU.
(a)
(b)